Why Cefalexin is Given Four Times Daily
Cefalexin is traditionally prescribed four times daily because of its short serum elimination half-life of approximately 1 hour, which requires frequent dosing to maintain therapeutic drug levels throughout the day 1, 2.
Pharmacokinetic Rationale
The fundamental reason for four-times-daily dosing stems from cefalexin's pharmacokinetic properties:
- Short half-life: Cefalexin has a serum elimination half-life of ≤1 hour, meaning drug concentrations drop rapidly after each dose 2
- Maintaining therapeutic levels: To ensure continuous bacterial killing and prevent treatment failure, the drug must be redosed before concentrations fall below the minimum inhibitory concentration (MIC) for target pathogens
- High urinary recovery: Despite the short half-life, cefalexin achieves >80% urinary recovery, making it particularly effective for urinary tract infections 2
FDA-Approved Dosing
The FDA label explicitly states: "The usual adult dose is 250 mg every 6 hours" for most infections 1. This every-6-hour schedule translates to four times daily (q.i.d.) dosing. For more severe infections or less susceptible organisms, 500 mg every 6 hours may be used 1.
Important Clinical Nuance: Alternative Dosing May Be Appropriate
While four-times-daily dosing remains the standard, emerging evidence supports that twice-daily dosing can be equally effective for certain infections, which addresses a critical adherence issue:
- Skin and soft tissue infections: A 1981 study demonstrated that twice-daily cefalexin was equally effective (>97% efficacy) compared to four-times-daily dosing for dermatologic infections 3
- Uncomplicated UTIs: A 2023 multicenter study found no difference in treatment failure between 500 mg twice daily versus four times daily (12.7% vs 17%, p=0.343) 4
- Streptococcal pharyngitis and uncomplicated cystitis: The FDA label itself allows for 500 mg every 12 hours (twice daily) for these specific conditions 1
Practical Considerations
Common pitfall: Prescribing four-times-daily dosing when twice-daily would suffice, leading to poor adherence and treatment failure. Consider:
- For uncomplicated skin infections, pharyngitis, and cystitis: 500 mg twice daily is FDA-approved and equally effective 1, 3, 4
- For more severe infections or bone/joint infections: Higher doses (up to 1.5 g) three times daily may be appropriate 5
- For standard moderate infections: The traditional 250-500 mg four times daily remains appropriate 1
Why Not Other Cephalosporins?
Newer oral cephalosporins (cefadroxil, cefixime, cefpodoxime) have longer half-lives (>1.25 hours) allowing once or twice-daily dosing 2, 6. However, cefalexin remains widely used due to its excellent bioavailability, superior side effect profile, and cost-effectiveness 7.
The key clinical decision: Match the dosing frequency to the infection severity and type. For uncomplicated infections where twice-daily dosing is validated, prioritize adherence over traditional four-times-daily scheduling.